From the cBioPortal data, we discovered that the proportions of ABAT gene shallow deletion, diploid, gain, and amplification were 28%, 60%, 11%, and 1%, respectively, in HCC (Figure 7A). The gene discussed is ABAT; the disease is hepatocellular carcinoma.